CompanyGraph
Shanghai Kindly Enterprise Development Group Co., Ltd.
603987 · SSE · China
kdlchina.cnFinancials as of FY2025
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleLevered free cash flow is $39.3M, above the global median of $18.73M
- FinancialsAltman Z-Score 3.33: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.24%
Annual Rate
CNY 0.17Paid annual
Payout Ratio
32.1%Sustainable
Payback Period
44.6 yr
Last Ex-Dividend
Jun 3, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.33BCNY497.02M · vs all stocks (USD)
Trailing P/E
13.87xvs Medical Instruments & Supplies peers
Revenue (TTM)
2.26BCNY337.83M · vs all stocks (USD)
Profit Margin
10.06%vs Medical Instruments & Supplies peers
Beta
0.3170xvs all stocks
52-Week Change
-13.51%vs all stocks
Market Capitalization
3.33BCNY497.02M · vs all stocks (USD)
Enterprise Value
3.66BCNY546.95M · vs all stocks (USD)
Trailing P/E
13.87xvs Medical Instruments & Supplies peers
Forward P/E
7.28xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
1.42xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
1.13xvs Medical Instruments & Supplies peers
Enterprise to Revenue
1.62xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
9.10xvs Medical Instruments & Supplies peers
Gross Margin
30.91%vs Medical Instruments & Supplies peers
Profit Margin
10.06%vs Medical Instruments & Supplies peers
Operating Margin
11.06%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
3.81%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
8.07%vs Medical Instruments & Supplies peers
Revenue (TTM)
2.26BCNY337.83M · vs all stocks (USD)
Revenue per Share (TTM)
5.27CNYUpdated Sep 22, 2026Quarterly Revenue Growth
-4.30%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
726.36MCNY108.47M · vs all stocks (USD)
EBITDA (TTM)
306.21MCNY45.73M · vs all stocks (USD)
Net Income (TTM)
227.56MCNY33.98M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-9.60%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
449.91MCNY67.19M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
263.16MCNY39.30M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1700CNYUpdated Sep 22, 2026Trailing Annual Dividend Yield
2.24%vs all stocks
Payout Ratio
32.08%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
341.04MCNYFY2025 · Dec 31, 2025Revenue
2.30BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.54BCNYFY2025 · Dec 31, 2025Gross Profit
759.93MCNYFY2025 · Dec 31, 2025Operating Income
291.02MCNY43.46M · vs all stocks (USD)
Pre-tax Income
307.63MCNYFY2025 · Dec 31, 2025Income Tax Expense
46.55MCNYFY2025 · Dec 31, 2025Net Income
261.08MCNYFY2025 · Dec 31, 2025EBIT
324.65MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
498.05MCNYFY2025 · Dec 31, 2025Research & Development
90.48MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
122.09MCNYFY2025 · Dec 31, 2025Other Operating Expenses
25.91MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
2.32MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
17.02MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.5500CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.5500CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
437.00MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
437.00MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
261.08MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-20.73MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
232.16MCNYFY2025 · Dec 31, 2025Free Cash Flow
86.09MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
472.10MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
261.08MCNYFY2025 · Dec 31, 2025Other Non-cash Items
19.46MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-93.64MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
45.26MCNYFY2025 · Dec 31, 2025Capital Expenditures
-146.07MCNYFY2025 · Dec 31, 2025Net Acquisitions
18.73MCNYFY2025 · Dec 31, 2025Purchase of Investments
-3.00MCNYFY2025 · Dec 31, 2025Sale of Investments
1.98MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-128.35MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
656.90MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-712.45MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-83.11MCNYFY2025 · Dec 31, 2025Other Financing Charges
-6.28MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-144.94MCNYFY2025 · Dec 31, 2025Shares Outstanding
436.79MSharesUpdated Sep 22, 2026Float Shares
248.66MSharesUpdated Sep 22, 2026% Held by Insiders
43.89%vs all stocks
% Held by Institutions
2.76%vs all stocks
Total Cash (MRQ)
480.15MCNY71.70M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.10CNYUpdated Sep 22, 2026Total Debt (MRQ)
634.13MCNY94.69M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.2028xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
1.76xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
6.48CNYUpdated Sep 22, 2026Total Assets
4.19BCNY626.08M · vs all stocks (USD)
Total Current Assets
1.92BCNYFY2025 · Dec 31, 2025Total Liabilities
1.14BCNYFY2025 · Dec 31, 2025Total Non-current Assets
2.27BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
49.57MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.09BCNYFY2025 · Dec 31, 2025Cash
472.10MCNYFY2025 · Dec 31, 2025Cash Equivalents
19.85MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
491.95MCNYFY2025 · Dec 31, 2025Accounts Receivable
961.50MCNYFY2025 · Dec 31, 2025Inventory
383.03MCNYFY2025 · Dec 31, 2025Accounts Payable
300.99MCNYFY2025 · Dec 31, 2025Short-term Debt
553.19MCNYFY2025 · Dec 31, 2025Other Current Liabilities
7.15MCNYFY2025 · Dec 31, 2025Long-term Debt
3.71MCNYFY2025 · Dec 31, 2025Common Stock (Book)
436.79MCNYFY2025 · Dec 31, 2025Retained Earnings
1.59BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
3.06BCNY456.40M · vs all stocks (USD)
52-Week Low
6.72CNYUpdated Sep 22, 202652-Week High
9.60CNYUpdated Sep 22, 202652-Week Change
-13.51%vs all stocks
Beta
0.3170xvs all stocks
50-Day MA
7.45CNYUpdated Sep 22, 2026200-Day MA
8.22CNYUpdated Sep 22, 2026Avg 10-Day Volume
2.80MSharesUpdated Sep 22, 2026Avg 30-Day Volume
4.01MSharesUpdated Sep 22, 2026Diluted EPS (TTM)
0.5300CNYUpdated Sep 22, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.33: safe zoneNotable
Altman Z-Score: 3.33
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Levered free cash flow is $39.3M, above the global median of $18.73MNotable
Levered free cash flow (USD): 39,297,869.164Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Hunan Lead Power Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Adicon Holdings Ltd
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
West Coast Paper Mills Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Guangdong Huafeng New Energy Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Chengdu KSW Technologies Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
NewTechWood Corporation
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Nemak S.A.B. de C.V.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Nippon Signal Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Anfu Ce Link Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Beijing Centergate Technologies (Holding) Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRule